WESCO’s fourth quarter saw a muted market response, as the company's non-GAAP earnings per share fell short of Wall Street’s expectations despite sales growth in line with analyst forecasts.

Michael H. Carrel: 2025 was an exceptional year at AtriCure, Inc. with achievements across our business. This trial is evaluating the benefit of our AtriClip devices on non-AFib patients undergoing ...

Wright: What we see with senior patients is this balance of treating chronic conditions, like chronic pain. One of the issues ...

LI.FI, a powerful non-custodial toolkit that enables developers to embed DeFi actions like swaps and bridging within their applications, today announced that it has launched LI.FI Composer, a ...